Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Thrombosis Research
|
February 15, 1991
Reproducibility of one-stage, two-stage and chromogenic assays of factor VIII activity: a multi-center study
S Cinotti, G Longo, A Messori, et al.
Thrombosis Research
|
March 15, 1992
Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity
A Messori, M Morfini, M Blomback, et al.
The New England Journal of Medicine
|
April 9, 1987
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions
K Schimpf, P M Mannucci, W Kreutz, et al.
Transfusion
|
March 1, 1995
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group
A Shapiro, T Abe, L M Aledort, et al.
The New England Journal of Medicine
|
October 26, 1989
Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate
K Schimpf, H H Brackmann, W Kreuz, et al.
Transfusion
|
February 1, 1992
Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group
P M Mannucci, K Schimpf, T Abe, et al.
Journal of AOAC International
|
October 13, 2017
Determination of Total Biotin by Liquid Chromatography Coupled with Immunoaffinity Column Cleanup Extraction: Multilaboratory Testing, Final Action 2016.02
George Joseph, Ranjani Devi, Elaine C Marley, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Thrombosis Research
|
February 15, 1991
Reproducibility of one-stage, two-stage and chromogenic assays of factor VIII activity: a multi-center study
S Cinotti, G Longo, A Messori, et al.
Thrombosis Research
|
March 15, 1992
Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity
A Messori, M Morfini, M Blomback, et al.
The New England Journal of Medicine
|
April 9, 1987
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions
K Schimpf, P M Mannucci, W Kreutz, et al.
Transfusion
|
March 1, 1995
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group
A Shapiro, T Abe, L M Aledort, et al.
The New England Journal of Medicine
|
October 26, 1989
Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate
K Schimpf, H H Brackmann, W Kreuz, et al.
Transfusion
|
February 1, 1992
Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group
P M Mannucci, K Schimpf, T Abe, et al.
Journal of AOAC International
|
October 13, 2017
Determination of Total Biotin by Liquid Chromatography Coupled with Immunoaffinity Column Cleanup Extraction: Multilaboratory Testing, Final Action 2016.02
George Joseph, Ranjani Devi, Elaine C Marley, et al.
Page
of 5